Form D · Biotechnology
28bio, Inc.
Metairie, LA · CIK 0001769360
Offering snapshot reported Oct 29, 2026 · SEC filing
- Reported sold
- $8.52M Offering amount: $8.52M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 21, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$6,525,000 → $8,524,945
- Reported investors8 → 10
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 29, 2026 | Amendment | $8,524,945 | $1,999,945vs Jan 27, 2026 | 10 | SEC filing |
| Jan 27, 2026 | Amendment | $6,525,000 | No comparison | 8 | SEC filing |
| Jun 24, 2025 | Initial | $1,775,000 | No comparison | 2 | SEC filing |
| Nov 22, 2024 | Initial | $3,684,771 | No comparison | 21 | SEC filing |
| Jun 10, 2021 | Amendment | $6,056,462 | No comparison | Not reported | SEC filing |
| Jun 15, 2020 | Initial | $1,965,997 | No comparison | 7 | SEC filing |
| Mar 5, 2019 | Initial | $1,133,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $270K
- Finders' fees
- $0
- Form D file number
- 021-549709
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Covington Associates LLC | 127437 | Ian Dunn · CRD 4672426 |
Source: Form D, filed Oct 29, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Benjamin Cappiello | Executive |
| Lowry Curley | Director, Executive |
| J. Lowry Curley | Director, Executive |
| Paul Friel | Director |
| Thomas Hartung | Executive |
| Michael Katz | Director |
| Miklos Kobor | Director |
| Monica Metea | Executive |
| Michael Moore | Executive |
| Dale Pfost | Director |
| Alif Saleh | Director, Executive |
| Jeffrey Silverman | Director |
| David Weiner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4224 Houma Blvd., Suite 224
Metairie, LA, 70006
Metairie, LA, 70006